Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEACH: Levetiracetam for Seizure Prevention in Acute Intracerebral Haemorrhage
NCT02631759Phase 3Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Oct 2016
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in intracerebral hemorrhage (ICH) comparing Levetiracetam with Placebo (2 arms). Primary endpoint: Occurrence of at least one clinical or electrical epileptic seizure recorded on continuous 48h holter EEG. Started Oct 2016; status: completed.
02
Drugs
levetiracetam
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT02631759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02631759.